title: Prevention of post-transfusion cytomegalovirus: leucoreduction or screening?
authors.affiliation: Blood Bank North Holland (Sanquin) Plesmanlaan 125 NL - 1066 CX Amsterdam, The Netherlands.
authors.forename: H W
authors.initials: HW
authors.lastname: Reesink
authors.forename: C P
authors.initials: CP
authors.lastname: Engelfriet
authors.forename: G E
authors.initials: GE
authors.lastname: Tegtmeier
authors.forename: J
authors.initials: J
authors.lastname: O'Riordan
authors.forename: R
authors.initials: R
authors.lastname: Eglin
authors.forename: J A J
authors.initials: JA
authors.lastname: Barbara
authors.forename: P
authors.initials: P
authors.lastname: Flanagan
authors.forename: C K
authors.initials: CK
authors.lastname: Lin
authors.forename: W
authors.initials: W
authors.lastname: Rawlinson
authors.forename: L
authors.initials: L
authors.lastname: Muylle
authors.forename: S
authors.initials: S
authors.lastname: Wendel
authors.forename: S
authors.initials: S
authors.lastname: Biagini
authors.forename: A E
authors.initials: AE
authors.lastname: Lazar
authors.forename: T
authors.initials: T
authors.lastname: Krusius
authors.forename: E
authors.initials: E
authors.lastname: Alitupa
authors.forename: L
authors.initials: L
authors.lastname: Grillner
authors.forename: W
authors.initials: W
authors.lastname: Preiser
authors.forename: H W
authors.initials: HW
authors.lastname: Doerr
authors.forename: A
authors.initials: A
authors.lastname: Brand
authors.forename: B
authors.initials: B
authors.lastname: Zupanska
authors.forename: E
authors.initials: E
authors.lastname: Brojer
authors.forename: M
authors.initials: M
authors.lastname: Degré
mesh_terms: D016913:Blood Component Transfusion / Q000009:adverse effects / Q000592:standards*; D002469:Cell Separation; D003586:Cytomegalovirus Infections / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D007962:Leukocytes; D008403:Mass Screening; D012698:Serologic Tests